PRF Technologies (PRFX) Research & Development (2020 - 2024)
PRF Technologies (PRFX) recorded quarterly Research & Development of -$16.1 million in Q2 2024, down 440.55% on a QoQ basis from $4.7 million in Q1 2024, and down 1396.07% year-over-year from $1.2 million in Q3 2023.
PRF Technologies (PRFX) Research & Development (2020 - 2024) Analysis & Trends
PRF Technologies has disclosed Research & Development across 5 years of filings, most recently posting -$16.1 million for Q2 2024.
- Quarterly Research & Development fell 1396.07% year-over-year to -$16.1 million in Q2 2024, while the trailing twelve-month figure through Jun 2024 was -$8.1 million (down 241.64% YoY) and the FY2025 annual result came in at $1.1 million, down 90.29% from the prior year.
- Research & Development eased to -$16.1 million in Q2 2024, from $4.7 million in the prior quarter.
- Over five years, Research & Development peaked at $5.2 million in Q4 2021 and troughed at -$16.1 million in Q2 2024.
- A 5-year average of $125777.8 and a median of $819500.0 in 2022 frame the typical range for Research & Development.
- Biggest YoY gain for Research & Development was 6631.71% in 2021; the steepest drop was 4387.5% in 2021.
- Tracing PRFX's Research & Development over 5 years: stood at $446000.0 in 2020, then jumped by 1057.85% to $5.2 million in 2021, then slumped by 62.26% to $1.9 million in 2022, then surged by 40.89% to $2.7 million in 2023, then tumbled by 688.09% to -$16.1 million in 2024.
- Business Quant data shows PRFX's Research & Development at -$16.1 million in Q2 2024, $4.7 million in Q1 2024, and $2.7 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 222.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 180.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 138.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 934,363.43 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 296.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 97.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 103.35 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 39.38 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 46.94 Mn |
| 10 | PRF Technologies | 907,162.18 | -2.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -16.15 Mn |
| Mar 31, 2024 | 4.74 Mn |
| Dec 31, 2023 | 2.75 Mn |
| Sep 30, 2023 | 589,000.00 |
| Jun 30, 2023 | 1.25 Mn |
| Mar 31, 2023 | 1.45 Mn |
| Dec 31, 2022 | 1.95 Mn |
| Sep 30, 2022 | 1.05 Mn |
| Jun 30, 2022 | 2.10 Mn |
| Mar 31, 2022 | -680,000.00 |
| Dec 31, 2021 | 5.16 Mn |
| Sep 30, 2021 | -4.04 Mn |
| Jun 30, 2021 | 2.76 Mn |
| Mar 31, 2021 | -1.03 Mn |
| Dec 31, 2020 | 446,000.00 |
| Sep 30, 2020 | -157,000.00 |
| Jun 30, 2020 | 41,000.00 |
| Mar 31, 2020 | 24,000.00 |